T-cell lymphoma: Difference between revisions
Jump to navigation
Jump to search
| Line 40: | Line 40: | ||
==Treatment== | ==Treatment== | ||
[[T-cell lymphoma medical therapy|Medical therapy]] | [[T-cell lymphoma surgery| | [[T-cell lymphoma medical therapy|Medical therapy]] | [[T-cell lymphoma surgery|Surgery]] | [[T-cell lymphoma primary prevention|Primary Prevention]] | [[T-cell lymphoma secondary prevention|Secondary Prevention]] | [[T-cell lymphoma cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[T-cell lymphoma future or investigational therapies|Future or Investigational Therapies]] | ||
==See also== | ==See also== | ||
* [[B-cell lymphoma]] | * [[B-cell lymphoma]] | ||
Revision as of 15:39, 18 September 2012
For patient information click here.
| T-cell lymphoma | |
| MeSH | D016399 |
|---|---|
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating T-cell lymphoma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Staging | Laboratory Findings | X Ray | CT | MRI | Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
See also